eHealth, Inc. (NASDAQ:EHTH) recently ticked higher on weak volume. About 328379 contracts were traded on 27-Jun-19 compared to daily average volume of 431940 shares. The first sale was made at $78.82 but later the stock became weaker, and closed with a gain of 6.19%. It was last traded at $82.21 apiece.

eHealth, Inc. (EHTH): Outperform Candidate With 11.56% Upside Potential

eHealth, Inc. is maintained at an average outperform rating by 8 stock analysts, and there are at least 7.43% of shares outstanding that are currently legally short sold. The shares went up by 25.15% in value last month. Year-to-date it jumped 113.98%. Analysts are turning out to be more optimistic than before, with 6 of analysts who cover eHealth, Inc. (NASDAQ:EHTH) advice adding it to buy candidate list. Wall Street experts also assign a $91.71 price target on eHealth, Inc., pointing towards a 11.56% rally from current levels. The stock is trading for about -4.02% less than its 52-week high.

eHealth, Inc. Reports -62.13% Sales Growth

eHealth, Inc. (EHTH) remained successful in beating the consensus-estimated -$0.1 as it actually earned $0.33 per share in its last reported financial results. Revenue, on the other hand, scored -62.13% growth from the previous quarter, coming up with $51.1 million.

EHTH Adds 2.7% In A Week

This company shares (EHTH) so far managed to recover 285.96% since collapsing to its 52-week low. Over a week, it has seen its stock price volatility to stay at 5.98% while widening the period to a month, volatility was 5.35%. The share price has already crossed its 20 days moving average, floating at a distance of 10.29% and sits 22.66% higher versus its 50 days moving average. When looking at the past five sessions, the stock returned 2.7% gains and is up by 64.91% compared with its 200-day moving average of $58.23. Also, eHealth, Inc. (EHTH) needs to expand a 254.35% increase it experienced over the past twelve months.

Acer Therapeutics Inc. (NASDAQ:ACER) Consensus Call At 1.7

As regular trading ended, Acer Therapeutics Inc. (ACER) stock brought in a -$0.4 drop to $3.45. The day started at a price of $4.06 but then traded as high as $4.1 before giving part of the gains back. As for this week, analysts appear content to stick with their bright outlook with the consensus call at 1.7. Acer Therapeutics Inc. is given 1 buy-equivalent recommendations, 0 sells and 3 holds. The company shares sank -89.88% from their peak of $34.1 and now has a $33.22 million market value of equity.

Acer Therapeutics Inc. Could Grow 1389.86% More

ACER’s mean recommendation on Reuter’s scale improved from 1.67 thirty days ago to 2.33 now, which indicates a hold consensus from the analyst community. They see Acer Therapeutics Inc. (ACER) price hitting a mean target of $51.4 a share, meaning the stock still has potential that could lift the price another 1389.86% . Also, the recent close suggests the stock is underpriced by 189.86% compared to the most bullish target.

Acer Therapeutics Inc. (ACER) Returns -82.85% This Year

The company had seen its current volume reaching at 1479437 shares in the last trade. That compares with the recent volume average of 1800280. At the close of regular trading, its last week’s stock price volatility was 9.69% which for the month reaches 17.52%. Acer Therapeutics Inc. dipped to as low as $3.61 throughout the day and has returned -82.85% in this year. At one point in the past year, the shares traded as low as $3.61 but has recovered -4.43% since then. [T4]